Active, Not Recruiting Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers NCT02466971 Conditions Advanced Vaginal Adenocarcinoma, Advanced Vaginal Adenosquamous Carcinoma, Advanced Vaginal Squamous Cell Carcinoma, +33 more Locations University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States Anchorage Associates in Radiation Medicine — Anchorage, Alaska, United States Alaska Breast Care and Surgery LLC — Anchorage, Alaska, United States Alaska Oncology and Hematology LLC — Anchorage, Alaska, United States View all 381 locations View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer NCT02595879 Conditions Advanced Cervical Adenocarcinoma, Advanced Cervical Adenosquamous Carcinoma, Advanced Cervical Squamous Cell Carcinoma, +23 more Locations University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States Los Angeles General Medical Center — Los Angeles, California, United States USC / Norris Comprehensive Cancer Center — Los Angeles, California, United States Keck Medical Center of USC Pasadena — Pasadena, California, United States View all 17 locations View more locations Show fewer locations Loading locations... View Trial Details
